CD274 and nonpapillary renal cell carcinoma: While the treatment paradigm for metastatic clear cell renal cell carcinoma (ccRCC) has undergone rapid evolution in the previous three decades, immune checkpoint inhibitors (ICIs) that target and block programmed death 1 (PD-1) or programmed death-ligand 1 (PD-L1) have resulted in further drastic shifts.